Teva Pharma (TEVA) Gains on Bill Miller Mention
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- S&P 500 ends higher as traders shift from AI to healthcare
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent steady as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
Tweet
Share
E-mail
Get Alerts TEVA Hot Sheet
Join SI Premium – FREE
Teva Pharma (NYSE: TEVA) gained mid-day after famed investor Bill Miller of the Miller Value Fund called the stock his number one pick on CNBC.
Miller thinks TEVA can grow to $25-$30 per share.
Shares quickly rose 4% after he mentioned it.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Perplexity to open source its AI security software SPACE - Semafor
- Teva to Host R&D Day on Wednesday, November 11 in New York City
- Nasdaq network disruption hits US equities data feeds from Carteret
Create E-mail Alert Related Categories
Trader TalkRelated Entities
Bill MillerSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
